Pathogenic T cells in MOBP-induced murine EAE are predominantly focused to recognition of MOBP21F and MOBP27P epitopic residues (Q81437623)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17935073%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

Pathogenic T cells in MOBP-induced murine EAE are predominantly focused to recognition of MOBP21F and MOBP27P epitopic residues (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17935073%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Nathali Kaushansky

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17935073%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Rina Zilkha-Falb

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17935073%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Reut Hemo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17935073%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Hans Lassman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17935073%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Miriam Eisenstein

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17935073%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Aldema Sas

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17935073%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Avraham Ben-Nun

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17935073%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

1 November 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17935073%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

8 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17935073%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17935073%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

3281-3292

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17935073%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17935073%20AND%20SRC:MED&resulttype=core&format=json

Immunology of multiple sclerosis

8 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

T-cell responses to myelin antigens in multiple sclerosis; relevance of the predominant autoimmune reactivity to myelin oligodendrocyte glycoprotein.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

Developmental expression of the myelin gene MOBP in the rat nervous system.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

Molecular and developmental characterization of novel cDNAs of the myelin-associated/oligodendrocytic basic protein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

Morphometric analysis of the myelin-associated oligodendrocytic basic protein-deficient mouse reveals a possible role for myelin-associated oligodendrocytic basic protein in regulating axonal diameter

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

The central nervous system-specific myelin oligodendrocytic basic protein (MOBP) is encephalitogenic and a potential target antigen in multiple sclerosis (MS).

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

The myelin-associated oligodendrocytic basic protein region MOBP15-36 encompasses the immunodominant major encephalitogenic epitope(s) for SJL/J mice and predicted epitope(s) for multiple sclerosis-associated HLA-DRB1*1501.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

Myelin-associated oligodendrocytic basic protein: identification of an encephalitogenic epitope and association with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

Encephalitogenicity of myelin-associated oligodendrocytic basic protein and 2',3'-cyclic nucleotide 3'-phosphodiesterase for BALB/c and SJL mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

T Cell Recognition in Experimental Autoimmune Encephalomyelitis: Prospects for Immune Intervention with Synthetic Peptides

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

The specificity of TCR/pMHC interaction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

Crystal structure of I-Ak in complex with a dominant epitope of lysozyme

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

Alternate interactions define the binding of peptides to the MHC molecule IA(b).

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

The crystal structure of a T cell receptor in complex with peptide and MHC class II

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

Amelioration of relapsing experimental autoimmune encephalomyelitis with altered myelin basic protein peptides involves different cellular mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

Induction of a non-encephalitogenic type 2 T helper-cell autoimmune responsein multiple sclerosis after administration of an altered peptide ligand ina placebo-controlled, randomized phase II trial

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

Encephalitogenic and tolerogenic potential of altered peptide ligands of MOG and PLP in Biozzi ABH mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

Down-regulation of myasthenogenic T cell responses by a dual altered peptide ligand via CD4+CD25+-regulated events leading to apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

A dual altered peptide ligand down-regulates myasthenogenic T cell responses and reverses experimental autoimmune myasthenia gravis via up-regulation of Fas-FasL-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

Regulatory CD4+ T cells and the control of autoimmune disease.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptide

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

Regulatory T cells in immunologic self-tolerance and autoimmune disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

Regulatory T cells in autoimmmunity*.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

A dual altered peptide ligand down-regulates myasthenogenic T cell responses by up-regulating CD25- and CTLA-4-expressing CD4+T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

Peptide-specific prevention of experimental allergic encephalomyelitis. Neonatal tolerance induced to the dominant T cell determinant of myelin basic protein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

Amelioration of Autoimmune Encephalomyelitis by Myelin Basic Protein Synthetic Peptide-Induced Anergy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

Induction of EAE in mice with recombinant human MOG, and treatment of EAE with a MOG peptide.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

Anatomy of T cell autoimmunity to myelin oligodendrocyte glycoprotein (MOG): prime role of MOG44F in selection and control of MOG-reactive T cells in H-2b mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

T-cells specific for soluble recombinant oligodendrocyte-specific protein induce severe clinical experimental autoimmune encephalomyelitis in H-2(b) and H-2(s) mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

Multiple sclerosis candidate autoantigens except myelin oligodendrocyte glycoprotein are transcribed in human thymus.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

Myelin/oligodendrocyte glycoprotein-deficient (MOG-deficient) mice reveal lack of immune tolerance to MOG in wild-type mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

Epitope specificity of autoreactive T and B cells associated with experimental autoimmune encephalomyelitis and optic neuritis induced by oligodendrocyte-specific protein in SJL/J mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737438

7 January 2021

Identifiers

DOI

10.1002/EJI.200737438

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17935073%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference